HOLLY BUSHART: Open Payments
NPI 1881855690 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,328 in 60 payments from 26 companies in 2025. Trend: 2023 $2,392 · 2024 $2,061 · 2025 $2,328
Food & beverage: $2,328
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $417 |
| JAZZ PHARMACEUTICALS INC. | 2 | $250 |
| Astellas Pharma US Inc | 4 | $201 |
| Celgene Corporation | 3 | $172 |
| SOBI, INC | 2 | $167 |
| Daiichi Sankyo Inc. | 5 | $131 |
| Novocure Inc. | 1 | $129 |
| Merck Sharp & Dohme LLC | 4 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Exelixis Inc. | 3 | $71 |
Products named: RYBREVANT, ZIIHERA, REBLOZYL, Vyloy, Optune Lua (NovoTTF-200T), Vonjo, KEYTRUDA, Enhertu.
Industry payments across TN — which companies pay providers there.
